Laboratory revenue cycle management encompasses every operational process connecting clinical laboratory services to collected Medicare reimbursement – and in August 2026, it has become the most actionable lever available to laboratory executives preparing for a confirmed payment shift. The Consolidated Appropriations Act, 2026, signed February 3, 2026, delayed all PAMA-related Clinical Laboratory Fee Schedule (CLFS) rate reductions through December 31, 2026 – the seventh Congressional intervention since PAMA was enacted [1]. But the reprieve is temporary.

As radiology medical billing stands now, revenue cycle processes don’t accurately reflect the extensive work they do out...
read more
The medical billing outsourcing market is experiencing unprecedented growth, with the global market size projected to re...
read more
In the wake of COVID, budget crunches, and labor shortages, many hospitals and health systems have been making the smart...
read more